RESUMO
Hydrogel nanocatalyst composed of nickel oxide (NiO) nanoparticles embedded in PVA-alginate hydrogels were potentially explored toward the reduction of anthropogenic water pollutants. The NiO nanoparticles was accomplished via green method using waste pineapple peel extract. The formation of the nanoparticles was affirmed from different analytical techniques such as UV-Vis, FTIR, XRD, TGA, FESEM, and EDS. Spherical NiO nanoparticles were obtained having an average size of 11.5 nm. The nano NiO were then integrated into PVA-alginate hydrogel matrix forming a nanocomposite hydrogel (PVALg@ NiO). The integration of nano NiO rendered an improved thermal stability to the parent hydrogel. The PVALg@ NiO hydrogel was utilized as a catalyst in the reduction of 4-nitrophenol (4-NP), potassium hexacyanoferrate (III), rhodamine B (RhB), methyl orange (MO), and malachite green (MG) in the presence of a reducing agent, i.e., NaBH4. Under optimized conditions, the reduction reactions were completed by 4.0 min and 3.0 min for 4-NP and potassium hexacyanoferrate (III), respectively, and the rate constant was estimated to be 1.14 min-1 and 2.15 min-1. The rate of reduction was found to be faster for the dyes and the respective rate constants were be 0.17 s-1 for RhB, MG and 0.05 s-1 for MO. The PVALg@ NiO hydrogel nanocatalyst demonstrated a recyclability of four runs without any perceptible diminution in its catalytic mettle. The efficacy of the PVALg@ NiO hydrogel nanocatalyst was further examined for the reduction of dyes in real water samples collected from different sources and the results affirm its high catalytic potential. Thus, this study paves the path for the development of a sustainable hydrogel nanocatalyst for reduction of hazardous pollutants in wastewater treatment.
RESUMO
The aim of this study was to investigate the efficacy and safety of Endoscopic Sinus Surgery (ESS) as a treatment modality for chronic rhinosinusitis refractory to maximal medical therapy in the elderly population. ESS has gained importance over the past 2-3 decades. A prospective review of outcome was done in fifty seven patients over age of 60 years who underwent ESS. They were evaluated preoperatively and postoperatively at 3, 6, and 12 months with a rigid nasal endoscopy scoring system, and the Sino Nasal Outcome Test-20 questionnaire. Data analysis was performed using the Student's t test to compare mean scores. All complications were noted. All of the patients in the study reported postoperative symptomatic improvement. And it was concluded that ESS in the geriatric population is a safe and effective treatment modality for rhinosinusitis which is refractory to medical therapy.
